Mouwasat Medical Servicesالمواساة
- Price
- 66.55 SAR
- Fair value
- 43.36 SAR
- Discount to fair value
- −53%
- Mkt cap
- 13.31B
- P/E
- 16.2×
- P/B
- 3.52×
- EV
- 13.80B
- Div yield
- 4.51%
- ROE
- 21.8%
- Net margin
- 25.5%
Current price66.55SAR
Fair value (est., median)43.36SAR
UndervaluedFair valueOvervalued
+53.5% above fair valueWould need to fall ~34.8% to reach fair value.
Median ofDCF 69.82DDM 43.36Graham 40.52Residual Income 43.96Earnings Power 36.8
Health Check
54.1
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Strong return on equity (21.8%).
- Healthy balance sheet.
Risks
- Trades 53.5% above estimated fair value.
- Low fair-value confidence — methods disagree or data is thin.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for detailsDemo series
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 4 years · FY2022–FY2025
| Metric | FY'22 | FY'23 | FY'24 | FY'25 | TTM'26 |
|---|---|---|---|---|---|
| Revenue | 2.33B | 2.71B | 2.88B | 3.22B | — |
| Net Income | 599.31M | 657.69M | 645.76M | 822.04M | 826.01M |
| Net Margin | 25.7% | 24.3% | 22.4% | 25.5% | — |
| Operating Cash Flow | 707.33M | 813.78M | 1.26B | 1.18B | — |
| OCF Margin | 30.3% | 30.1% | 43.6% | 36.5% | — |
| Capital Expenditure | 298.67M | 286.54M | 435.56M | 427.35M | — |
| Free Cash Flow | 408.65M | 527.24M | 820.87M | 750.37M | — |
| FCF Margin | 17.5% | 19.5% | 28.5% | 23.3% | — |
| FCF Conversion | 68.2% | 80.2% | 127.1% | 91.3% | — |
| EPS (Diluted) | 3.00/sh | 3.29/sh | 3.23/sh | 4.11/sh | 4.13/sh |
| Dividend / Share | 1.38/sh | 1.50/sh | 1.75/sh | 3.00/sh | — |
Dividend return (if you buy today)if you buy today
Dividend yield4.51%
Dividend / share3.00
If you invest
Shares (≈)150
Est. annual income450.00
At this rate, dividends alone return your capital in ~22.2 years.
Dividend history
Dividend / share & historical yield (SAR).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · SAR
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | — |
| 2025 | — | — | — | — | 3.00 | — |
| 2024 | — | — | — | — | 1.75 | — |
| 2023 | — | — | — | — | 1.50 | — |
| 2022 | — | — | — | — | 1.38 | — |
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
69.82
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
43.36
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
40.52
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
43.96
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
36.80
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)43.36
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 10.13%
- CAPM cost of equity
- 10.50%
- Risk-free rate
- 4.50%
- Equity risk premium
- 6.00%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 5
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Analyst Price Targets
1 houseHistorical — last published analyst views, not a current target.
Hajras fair value: 43.36
Aljazira Capital
as of 2022-11-08 · Mouwasat Medical Services Co. - Results Flash Note Q3-22
Hold
209.00
—
Wealth simulator
What if you'd invested in Mouwasat Medical Services regularly?
Starting year
- Invested
- 1K/yr · 1K total(2026 → today · 1 yrs)
- your value today is
- 1K SAR
- Total return
- +4.5%(+4.5% Dividends · 0.0% Capital gain)
- Annualised (IRR)
- +10.4%
Invested1KSAR
Dividends45SAR
Capital gain0SAR
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.